Illumina shareholders oust board chair, CEO survives Carl Icahn proxy battle

Hits: 3

Carl Icahn has accused Illumina’s management and board of poor oversight, particularly with regard to the company’s acquisition of cancer test maker Grail. Read More Go To Source

Be the first to comment

Leave a Reply

Your email address will not be published.


18 − 2 =